Menora Mivtachim Holdings’s Gilead Sciences GILD Stock Holding History

Menora Mivtachim Holdings’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-273,935	Closed	-$20.7M	–	100
2018 Q1	$20.7M	Hold	273,935	–	–	0.65%	57
2017 Q4	$19.6M	Buy	+273,935	New	+$20.8M	0.76%	55
2017 Q1	–	Sell	-401,110	Closed	-$28.7M	–	90
2016 Q4	$28.7M	Sell	401,110 -102,250	-20%	-$7.6M	1.47%	24
2016 Q3	$39.8M	Buy	503,360 +500	+0.1%	+$40.6K	2.19%	16
2016 Q2	$41.9M	Buy	502,860 +420	+0.1%	+$37.3K	2.37%	14
2016 Q1	$46.2M	Buy	502,440 +180	+0%	+$16.2K	2.76%	14
2015 Q4	$50.8M	Buy	502,260 +750	+0.1%	+$78K	3.24%	10
2015 Q3	$49.2M	Hold	501,510	–	–	3.67%	10
2015 Q2	$58.7M	Sell	501,510 -111,400	-18%	-$12.2M	4.46%	6
2015 Q1	$60.1M	Buy	612,910 +27,560	+5%	+$2.8M	4.86%	4
2014 Q4	$55.2M	Buy	585,350 +103,250	+21%	+$10.7M	4.84%	5
2014 Q3	$51.3M	Buy	+482,100	New	+$47.2M	3.53%	8

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Menora Mivtachim Holdings's GILD Position: Q2 2018 in Review

Menora Mivtachim Holdings sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 273,935 shares — an estimated $20.7M sold.

Menora Mivtachim Holdings first reported a position in GILD in Q3 2014 and held it in 12 quarters. The position peaked at $60.1M in Q1 2015. 1,523 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

Menora Mivtachim Holdings reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
Menora Mivtachim Holdings sold 273,935 Gilead Sciences shares in Q2 2018, an estimated $20.7M.
Menora Mivtachim Holdings first reported a position in Gilead Sciences in Q3 2014 and held it in 12 quarters.
Menora Mivtachim Holdings's Gilead Sciences position peaked at $60.1M in Q1 2015.
1,523 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2018, filed 1 Aug 2018.